GE recruits new allies
GE Medical Systems has signed licensing agreements with the Texas A&M University system and Beth Israel Deaconess Medical Center to develop new near-infrared-light imaging technologies. Efforts will focus on assessing the potential of these technologies
GE Medical Systems has signed licensing agreements with the Texas A&M University system and Beth Israel Deaconess Medical Center to develop new near-infrared-light imaging technologies. Efforts will focus on assessing the potential of these technologies to improve the detection, diagnosis, and treatment of cancers. The licensing agreements call for GE to work with the research institutions to advance technologies there for eventual FDA approval.
The A&M system technology, fluorescence-enhanced optical imaging and tomography, combines imaging sensitivity, tissue penetration, and tissue characterization as the means to detect and track disease progression. It also might be used in the development of new diagnostic and therapeutic agents. The Beth Israel Deaconess technology is an intraoperative near-infrared fluorescence imaging system that enables surgeons to visualize surgical anatomy and functional fluorescence simultaneously, noninvasively, and with high spatial resolution. Potential applications include image-guided sentinel lymph node mapping, image-guided cancer resection with real-time assessment of surgical margins, mapping of tumor and normal vasculature, image-guided avoidance of critical structures such as nerves, and detection of occult metastases.
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.
